The impact of the source of stem cells on the outcome of Autologous Stem Cell Transplantation (ASCT) for patients with myelodysplastic syndrome or acute myeloid leukemia following MDS
SourceBone Marrow Transplantation, 27, Suppl 1, (2001), pp. S70
Article / Letter to editor
Display more detailsDisplay less details
Bone Marrow Transplantation
iss. Suppl 1
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.